Idiopathic pulmonary fibrosis (IPF) is a severe, rapidly progressive diffuse lung disease. Several pathogenetic mechanisms have been hypothesized on the basis of the fibrotic lung damage occurring in this disease, and a potential profibrotic role of activated alveolar macrophages and their mediators in the pathogenesis of IPF was recently documented. This paper focuses on recent literature on potential biomarkers of IPF derived from activated alveolar macrophages. Biomarker discovery and clinical application are a recent topic of interest in the field of interstitial lung diseases (ILDs). Cytokines, CC-chemokines, and other macrophage-produced mediators are the most promising prognostic biomarkers. Many molecules have been proposed in the literature as potential biomarker of IPF; however, a rigorous validation is needed to confirm their clinical utility.
|Titolo:||Macrophage-derived biomarkers of idiopathic pulmonary fibrosis|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto:
|Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis.pdf||PDF editoriale||Open Access Visualizza/Apri|